A New ERA in Scleroderma Interstitial Lung Disease and Renal Crisis: Rationale for Early Use of Endothelin Receptor Antagonists

被引：0
|
作者：
Sunseri, M. [1 ]
Gershner, K. [1 ]
Gunther, I. [1 ]
Brosnahan, S. [1 ]
机构：
[1] NYU, Langone Med Ctr, New York, NY USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1523
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Distinct Actions of Endothelin A-Selective Versus Combined Endothelin A/B Receptor Antagonists in Early Diabetic Kidney Disease
    Saleh, Mohamed A.
    Pollock, Jennifer S.
    Pollock, David M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 338 (01): : 263 - 270
  • [32] Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease
    Abraham, DJ
    Vancheeswaran, R
    Dashwood, MR
    Rajkumar, VS
    Pantelides, P
    Xu, SW
    duBois, RM
    Black, CM
    AMERICAN JOURNAL OF PATHOLOGY, 1997, 151 (03): : 831 - 841
  • [33] Vasodilation of the renal micro-circulation by the combined use of endothelin EtA and EtB receptor antagonists.
    Inman, SR
    Stowe, NT
    Chen, RN
    Novick, AC
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1571 - A1571
  • [34] Scleroderma renal crisis during intravenous cyclophosphamide pulse therapy for complicated interstitial lung disease was successfully treated with angiotensin converting enzyme inhibitor and plasma exchange
    Nagamura, Norihiro
    Kin, Seikon
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2016, 78 (03): : 329 - 334
  • [35] Pulmonary Function Tests: High Rate of False Negatives in the Early Detection and Screening of Scleroderma Interstitial Lung Disease
    Suliman, Yossra A.
    Dobrota, Rucsandra
    Huscher, Doerte
    Thi Dan Linh Nguyen-Kim
    Maurer, Britta
    Jordan, Suzana
    Speich, Rudolf
    Frauenfelder, Thomas
    Distler, Oliver
    SWISS MEDICAL WEEKLY, 2015, 145 : 9S - 9S
  • [36] Survival and early outcomes following lung transplantation for interstitial lung disease associated with non-scleroderma connective tissue disease: a national cohort study
    Luo, C.
    Shi, J.
    Zhang, J.
    Lin, Y.
    Pan, Y.
    Zhang, J.
    Yang, C.
    Peng, G.
    He, J.
    Xu, X.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2025, 43 (03) : 477 - 485
  • [37] Pulmonary hypertension, interstitial lung disease, renal disease and macrovascular risk factor monitoring in scleroderma. How well are we doing?
    O'Rourke, K. P.
    Ahmed, I.
    Mittal, R.
    Robertson, L.
    RHEUMATOLOGY, 2006, 45 : I151 - I151
  • [38] Endothelin Receptor Antagonists Plus Sodium-Glucose Cotransporter 2 Inhibitors Poster Child for a New ERA of Combination Therapies?
    Limonte, Christine P.
    de Boer, Ian H.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10): : 1306 - 1308
  • [39] SURVIVAL BENEFIT OF EARLY USE OF CYCLOSPORINE IN DERMATOMYOSITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Go, D. J.
    Kang, E. H.
    Park, J. K.
    Kwon, H. M.
    Lee, Y. J.
    Shin, K. C.
    Lee, E. Y.
    Song, Y. W.
    Lee, E. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 97 - 97
  • [40] Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States
    Bernstein, Elana
    VanBuren, John
    Assassi, Shervin
    Castelino, Flavia
    Chung, Lorinda
    Correia, Chase
    Evnin, Luke
    Frech, Tracy
    Startup, Emily
    Gordon, Jessica
    Hant, Faye
    Hummers, Laura
    Sandorfi, Nora
    Shah, Ami
    Shanmugam, Victoria
    Steen, Virginia
    Khanna, Dinesh
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 795 - 798
12345